Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study.
about
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyCost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settingsCryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical ImplicationsPaucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndromeHIV & immune reconstitution inflammatory syndrome (IRIS)CNS-immune reconstitution inflammatory syndrome in the setting of HIV infection, part 2: discussion of neuro-immune reconstitution inflammatory syndrome with and without other pathogensIntegrated therapy for HIV and cryptococcosisHigh-Resolution Genetics Identifies the Lipid Transfer Protein Sec14p as Target for Antifungal ErgolinesHospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.A novel experimental model of Cryptococcus neoformans-related immune reconstitution inflammatory syndrome (IRIS) provides insights into pathogenesis.Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformansRisk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infectionCryptococcal meningitis: epidemiology and therapeutic options.Optimum timing of antiretroviral therapy for HIV-infected patients with concurrent serious opportunistic infections.Immunostimulation in the era of the metagenome.Symptomatic relapse of HIV-associated cryptococcal meningitis in South Africa: the role of inadequate secondary prophylaxisd-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.Update on opportunistic infections in the era of effective antiretroviral therapyMulti-analyte profiling of ten cytokines in South African HIV-infected patients with Immune Reconstitution Inflammatory Syndrome (IRIS).Comparison and temporal trends of three groups with cryptococcosis: HIV-infected, solid organ transplant, and HIV-negative/non-transplantPrevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious DiseasIncidence, clinical spectrum, risk factors and impact of HIV-associated immune reconstitution inflammatory syndrome in South Africa.Biomarkers in immune reconstitution inflammatory syndrome: signals from pathogenesisLong term 5-year survival of persons with cryptococcal meningitis or asymptomatic subclinical antigenemia in Uganda.Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsParadoxical immune reconstitution inflammatory syndrome in HIV-infected patients treated with combination antiretroviral therapy after AIDS-defining opportunistic infection.Central nervous system disorders after starting antiretroviral therapy in South Africa.Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates obtained through population-based surveillance in South Africa in 2002-2003 and 2007-2008.MORTALITY AFTER CLINICAL MANAGEMENT OF AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS IN KENYA.Immune reconstitution inflammatory syndrome in HIV-infected patientsEarly antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164Cerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitisCellular immune activation in cerebrospinal fluid from ugandans with cryptococcal meningitis and immune reconstitution inflammatory syndrome.Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.Treatment principles for Candida and Cryptococcus.Screening for cryptococcal antigenemia using the lateral flow assay in antiretroviral therapy-naïve HIV-positive adults at an Ethiopian hospital clinic.Significantly improved analytical sensitivity of lateral flow immunoassays by using thermal contrastA fatal case of AIDS-defining meningoencephalitis by C. neoformans, sensitive to antifungal therapyScreening for cryptococcal antigenemia in anti-retroviral naïve AIDS patients in benin city, Nigeria.
P2860
Q21144623-19628918-E270-4856-BA2C-EA70A2308D89Q24600270-CD6BC762-8F18-4408-9F96-CE3DB12638FBQ24629367-1BF38409-9C9D-489A-A1CD-86CA49A15787Q24630287-52E98A52-EDAE-48D1-AB59-DB0C3FAE836EQ26852805-FFA320DC-D2A5-4439-8153-EFF69CE49B94Q27011721-481FFC57-CD21-4A06-AA37-82DEFC072D06Q28077707-1E556BE7-0800-4FF7-9845-D6DF263D5B47Q28554843-44152B8A-EDA1-4EC1-9459-69402CF08980Q30252460-9C8A588D-90D7-4254-8B79-E03CBBEC5BCCQ30379272-4AE6D5D3-6C78-41B3-9355-23D328A0E505Q33557968-C31F5E1D-5C08-41E7-B743-598FE3F9FB09Q33628799-932468E5-4B59-4950-8B36-6A728D759749Q33633343-BDF2857C-1A9B-40B0-82D5-C492D09BC06AQ33823233-3B085C50-D12A-45BC-A2DF-9D17F91EA872Q33827416-21F58F2F-BE76-46D0-9018-688D2ABE6336Q33892987-17A0374A-A09F-474F-906F-083F16DA7840Q33941296-94D16A6F-79E2-4329-A941-BF1C8567F984Q34024416-1E72A2A4-446E-408A-BF7F-03A7D4650F71Q34085853-EDE19FBC-3E6D-4307-BE44-2BA51C5C2C3FQ34350857-6C32020A-7AAC-4885-BBB0-F590647E0E24Q34399223-6175F284-E55A-47AE-BDD1-001293582E01Q34407741-78BC3193-CC9D-44F9-9650-6EFB1D022828Q34477198-EEBA78DF-FBEA-4D8B-AB3C-4CE9DC6BDB2DQ34505245-D2B81BED-1BBF-4366-ACC0-A64F497DCC2BQ34516367-9D96C097-D7B1-429D-AF88-581F599B5FD2Q34516548-8E10F0D9-C879-48A4-A13D-85679FCFA7ABQ34633782-C8B3910B-A196-4CD7-8F6A-1515A5B5DAE4Q34799534-C0CE7A25-96A9-44CB-ACBC-487F1FCF85E5Q35004926-A449E4FF-8A9D-420C-96E5-0C90B24E2F94Q35073767-095BC216-96C9-452B-B820-E122B3F084B5Q35100818-2DF79E03-ABC3-40C9-84E8-ED48ACAFDAD5Q35244295-6030D53D-41E4-4478-B5F8-536DC544AD82Q35324835-49FA3864-02F2-431C-9F18-ECAEF94C835EQ35531947-805BF6CA-E65E-4893-B9CB-11EB0D4218BAQ35656939-54B202EC-D6BE-4D4E-B96E-2F4686FEE55BQ35664186-C2DAA914-5E03-44D3-87ED-1CC28BE5D82BQ35849300-741A4126-E31E-4B60-BA92-269B46F69E96Q35914676-38F4931A-C58C-4A90-AC9B-ADEB01592FC0Q35961629-C5F8A60F-DD55-4F79-92B1-81DBA4EE1A30Q36088621-F2215FFC-46B1-4EB7-BBCE-24E7E0F8C1E4
P2860
Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Immune reconstitution inflamma ...... ningitis: a prospective study.
@en
Immune reconstitution inflamma ...... ningitis: a prospective study.
@nl
type
label
Immune reconstitution inflamma ...... ningitis: a prospective study.
@en
Immune reconstitution inflamma ...... ningitis: a prospective study.
@nl
prefLabel
Immune reconstitution inflamma ...... ningitis: a prospective study.
@en
Immune reconstitution inflamma ...... ningitis: a prospective study.
@nl
P2093
P50
P1476
Immune reconstitution inflamma ...... ningitis: a prospective study.
@en
P2093
Angela Loyse
Anthony Williams
Kevin Rebe
Madeleine Hayes
Tihana Bicanic
P304
P356
10.1097/QAI.0B013E3181A56F2E
P407
P577
2009-06-01T00:00:00Z